No statistically significant changes were seen in the hematological and biochemical parameters in ACPA+ RA patients with the DRB1*04 or *10 alleles (Table 6), except for the MCV (P = 0.021). This evidence concerns the gene PRTN3 and rheumatoid arthritis.